bioMérieux Future Growth
Future criteria checks 3/6
bioMérieux is forecast to grow earnings and revenue by 14% and 7.2% per annum respectively. EPS is expected to grow by 13.8% per annum. Return on equity is forecast to be 12.5% in 3 years.
Key information
14.0%
Earnings growth rate
13.8%
EPS growth rate
| Medical Equipment earnings growth | 13.7% |
| Revenue growth rate | 7.2% |
| Future return on equity | 12.5% |
| Analyst coverage | Good |
| Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)
Apr 18
bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 17These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Mar 15bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
Jan 27bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward
Jan 06A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 16These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Oct 23bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger
Oct 05There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Jun 30Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down
Jun 09Is bioMérieux (EPA:BIM) Using Too Much Debt?
Mar 31The Return Trends At bioMérieux (EPA:BIM) Look Promising
Feb 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jan 27bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet
Dec 16bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth
Oct 18Is bioMérieux (EPA:BIM) Using Too Much Debt?
Sep 14Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital
Aug 11An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued
Jul 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jul 05bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
May 26Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns
May 11bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year
Apr 23bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85
Apr 09bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
Mar 25Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Mar 13I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease
Feb 08Why We Like The Returns At bioMérieux (EPA:BIM)
Dec 21Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 07Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching
Nov 07Is bioMérieux (EPA:BIM) A Risky Investment?
Oct 07Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital
Sep 22Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Aug 06There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital
Jun 15A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)
May 31Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Apr 30bioMérieux (EPA:BIM) Could Easily Take On More Debt
Mar 28The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested
Mar 13Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Feb 25If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns
Feb 09If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late
Jan 20
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?
Dec 30These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Dec 17Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?
Dec 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,593 | 602 | 514 | 896 | 5 |
| 12/31/2025 | 4,195 | 529 | 419 | 804 | 10 |
| 12/31/2024 | 3,907 | 471 | 439 | 804 | 10 |
| 12/31/2023 | 3,675 | 358 | 107 | 445 | N/A |
| 9/30/2023 | 3,688 | 372 | 140 | 459 | N/A |
| 6/30/2023 | 3,701 | 386 | 172 | 472 | N/A |
| 3/31/2023 | 3,645 | 419 | 180 | 474 | N/A |
| 12/31/2022 | 3,589 | 452 | 188 | 475 | N/A |
| 9/30/2022 | 3,525 | 502 | 297 | 583 | N/A |
| 6/30/2022 | 3,460 | 552 | 406 | 690 | N/A |
| 3/31/2022 | 3,418 | 577 | 470 | 757 | N/A |
| 12/31/2021 | 3,376 | 601 | 535 | 825 | N/A |
| 9/30/2021 | 3,296 | 555 | 424 | 716 | N/A |
| 6/30/2021 | 3,216 | 509 | 314 | 608 | N/A |
| 3/31/2021 | 3,167 | 457 | 310 | 595 | N/A |
| 12/31/2020 | 3,118 | 404 | 305 | 583 | N/A |
| 9/30/2020 | 2,997 | 355 | 261 | 538 | N/A |
| 6/30/2020 | 2,876 | 305 | 217 | 493 | N/A |
| 3/31/2020 | 2,775 | 289 | 176 | 451 | N/A |
| 12/31/2019 | 2,675 | 273 | 135 | 408 | N/A |
| 9/30/2019 | 2,601 | 268 | 160 | 419 | N/A |
| 6/30/2019 | 2,527 | 263 | 185 | 431 | N/A |
| 3/31/2019 | 2,474 | 260 | 179 | 415 | N/A |
| 12/31/2018 | 2,421 | 257 | 173 | 400 | N/A |
| 9/30/2018 | 2,372 | 264 | 162 | 370 | N/A |
| 6/30/2018 | 2,323 | 271 | 150 | 340 | N/A |
| 3/31/2018 | 2,306 | 255 | 154 | 341 | N/A |
| 12/31/2017 | 2,288 | 238 | 158 | 341 | N/A |
| 9/30/2017 | 2,262 | 216 | N/A | 340 | N/A |
| 6/30/2017 | 2,237 | 195 | N/A | 339 | N/A |
| 3/31/2017 | 2,170 | 187 | N/A | 337 | N/A |
| 12/31/2016 | 2,103 | 179 | N/A | 336 | N/A |
| 9/30/2016 | 2,068 | 158 | N/A | 339 | N/A |
| 6/30/2016 | 2,032 | 137 | N/A | 342 | N/A |
| 3/31/2016 | 1,998 | 124 | N/A | 326 | N/A |
| 12/31/2015 | 1,965 | 111 | N/A | 310 | N/A |
| 9/30/2015 | 1,908 | 127 | N/A | N/A | N/A |
| 6/30/2015 | 1,851 | 144 | N/A | 301 | N/A |
| 3/31/2015 | 1,775 | 140 | N/A | 300 | N/A |
| 12/31/2014 | 1,698 | 135 | N/A | 298 | N/A |
| 9/30/2014 | 1,656 | 135 | N/A | N/A | N/A |
| 6/30/2014 | 1,614 | 135 | N/A | 246 | N/A |
| 3/31/2014 | 1,601 | 150 | N/A | 243 | N/A |
| 12/31/2013 | 1,588 | 164 | N/A | 241 | N/A |
| 9/30/2013 | 1,581 | 150 | N/A | 240 | N/A |
| 6/30/2013 | 1,574 | 135 | N/A | 239 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIM's forecast earnings growth (14% per year) is above the savings rate (1%).
Earnings vs Market: BIM's earnings (14% per year) are forecast to grow faster than the French market (10.7% per year).
High Growth Earnings: BIM's earnings are forecast to grow, but not significantly.
Revenue vs Market: BIM's revenue (7.2% per year) is forecast to grow faster than the French market (5.8% per year).
High Growth Revenue: BIM's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BIM's Return on Equity is forecast to be low in 3 years time (12.5%).